Its announcement comes after studies showed that young people who were given the vaccine were at increased risk of developing narcolepsy, which causes sufferers to fall asleep unexpectedly.
Pandemrix, manufactured by the British pharmaceutical giant GlaxoSmithKline, was given to 30million people across Europe after the outbreak of swine flu – the H1N1 strain of the virus - that started in Mexico early in 2009.
It was approved by the European regulator in September that year but by the following August its safety was being reviewed after health officials in Finland claimed it had been linked to narcolepsy.
In total 335 cases of the sleeping disorder in people vaccinated with Pandemrix have been reported to GSK, with 10 suspected cases out of the 6million doses given in Britain.
One in four Israelis now engages in harmful substance use as the psychological fallout from Israel’s...
New York City’s famed Solomon R Guggenheim Museum was among a number of Manhattan buildings that...
Martha Lillard, who contracted polio at age five and spent most of her life dependent on...
The state of New York this week sued several companies over “forever chemicals,” a family of...
